221 related articles for article (PubMed ID: 12577148)
21. Clinical importance and cost of bacteremia caused by nosocomial multi drug resistant acinetobacter baumannii.
Gulen TA; Guner R; Celikbilek N; Keske S; Tasyaran M
Int J Infect Dis; 2015 Sep; 38():32-5. PubMed ID: 26129972
[TBL] [Abstract][Full Text] [Related]
22. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality.
Seifert H; Strate A; Pulverer G
Medicine (Baltimore); 1995 Nov; 74(6):340-9. PubMed ID: 7500897
[TBL] [Abstract][Full Text] [Related]
23. Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Liu CP; Shih SC; Wang NY; Wu AY; Sun FJ; Chow SF; Chen TL; Yan TR
J Microbiol Immunol Infect; 2016 Dec; 49(6):934-940. PubMed ID: 25553994
[TBL] [Abstract][Full Text] [Related]
24. Nosocomial infections due to Acinetobacter baumannii in a neurosurgery ICU.
Gulati S; Kapil A; Das B; Dwivedi SN; Mahapatra AK
Neurol India; 2001 Jun; 49(2):134-7. PubMed ID: 11447431
[TBL] [Abstract][Full Text] [Related]
25. Characteristics and Outcomes of Acinetobacter baumannii Infections in Critically Ill Patients with Cancer: A Matched Case-Control Study.
Nazer LH; Kharabsheh A; Rimawi D; Mubarak S; Hawari F
Microb Drug Resist; 2015 Oct; 21(5):556-61. PubMed ID: 26430944
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for extensive drug-resistance and mortality in geriatric inpatients with bacteremia caused by Acinetobacter baumannii.
Fu Q; Ye H; Liu S
Am J Infect Control; 2015 Aug; 43(8):857-60. PubMed ID: 25960385
[TBL] [Abstract][Full Text] [Related]
27. Prediction of patient outcome from Acinetobacter baumannii bacteremia with Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation (APACHE) II scores.
Chen SJ; Chao TF; Chiang MC; Kuo SC; Chen LY; Yin T; Chen TL; Fung CP
Intern Med; 2011; 50(8):871-7. PubMed ID: 21498935
[TBL] [Abstract][Full Text] [Related]
28. Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China.
Liu Q; Li W; Du X; Li W; Zhong T; Tang Y; Feng Y; Tao C; Xie Y
PLoS One; 2015; 10(6):e0130701. PubMed ID: 26083415
[TBL] [Abstract][Full Text] [Related]
29. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection.
Lee YT; Kuo SC; Yang SP; Lin YT; Tseng FC; Chen TL; Fung CP
Clin Infect Dis; 2012 Jul; 55(2):209-15. PubMed ID: 22495546
[TBL] [Abstract][Full Text] [Related]
30. [Factors associated with mortality in Acinetobacter baumannii infected intensive care unit patients].
Karabay O; Yahyaoğlu M; Oğütlü A; Sandıkçı O; Tuna N; Ceylan S
Mikrobiyol Bul; 2012 Apr; 46(2):335-7. PubMed ID: 22639324
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of drug resistance of Acinetobacter baumannii and its related factors in ICU].
Ma MY; Xu J; Yu N; Huang GM
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Nov; 25(11):686-9. PubMed ID: 24225215
[TBL] [Abstract][Full Text] [Related]
32. Comparison between bacteremia caused by Acinetobacter pittii and Acinetobacter nosocomialis.
Liu YM; Lee YT; Kuo SC; Chen TL; Liu CP; Liu CE
J Microbiol Immunol Infect; 2017 Feb; 50(1):62-67. PubMed ID: 25735795
[TBL] [Abstract][Full Text] [Related]
33. Case-control analysis of endemic Acinetobacter baumannii bacteremia in the neonatal intensive care unit.
Hsu JF; Chu SM; Lien R; Chiu CH; Chiang MC; Fu RH; Lee CW; Huang HR; Tsai MH
Am J Infect Control; 2014 Jan; 42(1):23-7. PubMed ID: 24176602
[TBL] [Abstract][Full Text] [Related]
34. Predictors of mortality in Acinetobacter baumannii bacteremia.
Chen HP; Chen TL; Lai CH; Fung CP; Wong WW; Yu KW; Liu CY
J Microbiol Immunol Infect; 2005 Apr; 38(2):127-36. PubMed ID: 15843858
[TBL] [Abstract][Full Text] [Related]
35. Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosa.
Blot S; Vandewoude K; Hoste E; Colardyn F
J Hosp Infect; 2003 Jan; 53(1):18-24. PubMed ID: 12495681
[TBL] [Abstract][Full Text] [Related]
36. Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia.
Lemos EV; de la Hoz FP; Alvis N; Einarson TR; Quevedo E; Castañeda C; Leon Y; Amado C; Cañon O; Kawai K
Clin Microbiol Infect; 2014 Feb; 20(2):174-80. PubMed ID: 23668595
[TBL] [Abstract][Full Text] [Related]
37. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital.
Alp E; Esel D; Yildiz O; Voss A; Melchers W; Doganay M
Scand J Infect Dis; 2006; 38(5):335-40. PubMed ID: 16709534
[TBL] [Abstract][Full Text] [Related]
38. Risk factors and outcome analysis of acinetobacter baumannii complex bacteremia in critical patients.
Lee HY; Chen CL; Wu SR; Huang CW; Chiu CH
Crit Care Med; 2014 May; 42(5):1081-8. PubMed ID: 24394630
[TBL] [Abstract][Full Text] [Related]
39. [Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit].
Bacakoğlu F; Korkmaz Ekren P; Taşbakan MS; Başarik B; Pullukçu H; Aydemir S; Gürgün A; Başoğlu OK
Mikrobiyol Bul; 2009 Oct; 43(4):575-85. PubMed ID: 20084910
[TBL] [Abstract][Full Text] [Related]
40. Mortality rates associated with multidrug-resistant Acinetobacter baumannii infection in surgical intensive care units.
Daniels TL; Deppen S; Arbogast PG; Griffin MR; Schaffner W; Talbot TR
Infect Control Hosp Epidemiol; 2008 Nov; 29(11):1080-3. PubMed ID: 18837670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
